Revisiting the role of CD4(+) T cells in cancer immunotherapy-new insights into old paradigms.

Revisiting the role of CD4(+) T cells in cancer immunotherapy-new insights into old paradigms.
复制标题

DOI:
10.1038/s41417-020-0183-x
复制
发表时间:
2021-03
影响因子:
6.4
通讯作者:
Toh HC
Toh HC
中科院分区:
医学3区
文献类型:
--
作者:
Tay RE;Richardson EK;Toh HC

文献摘要

参考文献

被引文献

相似文献

癌症免疫疗法已经彻底改变了癌症治疗,免疫检查点阻断(ICB)疗法和过继细胞疗法(ACT)越来越成为越来越多癌症适应症的标准治疗。虽然大多数癌症免疫疗法集中于利用抗肿瘤CD8+细胞毒性T细胞应答,但CD4+“辅助”T细胞的潜在作用在很大程度上仍处于背景中。在这篇综述中,我们概述了CD4+ T细胞在抗肿瘤免疫反应中的多方面作用,重点是最近的证据表明CD4+ T细胞发挥的作用比以前认为的更大。我们说明了它们的直接抗肿瘤效力和它们在指导针对肿瘤的持续免疫应答中的作用。我们进一步强调了新出现的观察结果,即CD4+ T细胞对肿瘤的反应往往是针对自身衍生的表位。这些最近的趋势提出了重要的问题和考虑,将深刻影响免疫疗法的合理设计,以充分利用免疫系统对抗癌症的潜力。
Cancer immunotherapy has revolutionised cancer treatment, with immune checkpoint blockade (ICB) therapy and adoptive cell therapy (ACT) increasingly becoming standard of care across a growing number of cancer indications. While the majority of cancer immunotherapies focus on harnessing the anti-tumour CD8+ cytotoxic T cell response, the potential role of CD4+ ‘helper’ T cells has largely remained in the background. In this review, we give an overview of the multifaceted role of CD4+ T cells in the anti-tumour immune response, with an emphasis on recent evidence that CD4+ T cells play a bigger role than previously thought. We illustrate their direct anti-tumour potency and their role in directing a sustained immune response against tumours. We further highlight the emerging observation that CD4+ T cell responses against tumours tend to be against self-derived epitopes. These recent trends raise vital questions and considerations that will profoundly affect the rational design of immunotherapies to leverage on the full potential of the immune system against cancer.
DOI: 10.4161/hv.23587
发表时间: 2013-05-01
影响因子: 4.8
作者:
Adotevi, Olivier;Dosset, Magalie;Borg, Christophe
通讯作者: Borg, Christophe
DOI: 10.1126/sciimmunol.aao4310
发表时间: 2019-01-01
期刊: SCIENCE IMMUNOLOGY
影响因子: 24.8
作者:
Ahmadzadeh, Mojgan;Pasetto, Anna;Rosenberg, Steven A.
通讯作者: Rosenberg, Steven A.
DOI: 10.3389/fonc.2014.00072
发表时间: 2014
影响因子: 4.7
作者:
Benencia F;Muccioli M;Alnaeeli M
通讯作者: Alnaeeli M
DOI: 10.1016/j.immuni.2007.08.014
发表时间: 2007-10-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Cao, Xuefang;Cai, Sheng F.;Ley, Timothy J.
通讯作者: Ley, Timothy J.
DOI: 10.4049/jimmunol.179.8.5033
发表时间: 2007-10-15
影响因子: 4.4
作者:
Bijker, Martijn S.;van den Eeden, Susan J. F.;van der Burg, Sjoerd H.
通讯作者: van der Burg, Sjoerd H.